The global appetite for GLP-1 medications like Ozempic, Wegovy and Mounjaro have created something far more dangerous than a cultural trend. It has created the perfect opening for cyber criminals who understand how desperation, scarcity and online misinformation intersect. As clinics struggle with shortages and manufacturers warn of supply limits extending well into 2025 and 2026, the demand for “easier,” faster or cheaper alternatives has exploded. Into this void, criminal groups have moved with extraordinary speed.

A few weeks ago, Check Point Research published an investigation into the rise of AI-powered pharmaceutical scams in the United States. We revealed how criminals were using generative AI to produce entire counterfeit ecosystems: fabricated doctors, lab reports, packaging, transformations, reviews and endorsements. But we also noted something subtle: scammers in the U.S. generally avoided misusing FDA or NIH branding. They were bold, but not that bold.

Across the UK, Spain, France, Italy and Germany, we found several examples of impersonation of national healthcare institutions. Criminals are not just selling fake GLP-1 products. They are cloning the identities of the organizations millions rely on for medical safety and public trust. They are doing it with precision, linguistic localization, culturally specific emotional triggers using generative AI systems capable of producing limitless variants of the same lie.

This is no longer simply counterfeit medicine. This is counterfeit medicine wrapped inside counterfeit authority.

The Industrialization of Fake Medical Realities

The starting point for nearly every scam is visual. Criminals understand that transformation imagery, like dramatic before-and-after photos, is among the most persuasive formats in the weight-loss category. And AI has now made this trivial.

SlimPure UK transformation photo

These images do not come from real patients. They are stitched together from a blend of stock photography, synthetic body reshaping and AI-assisted manipulation. Skin texture, lighting, body proportions: all are generated to mimic a plausible “journey,” often showing a woman in her 40s or 50s, the demographic currently driving Europe’s GLP-1 interest. The effect is exactly what criminals want, relatability, aspiration and urgency.

But the images are only the bait. Once a user clicks, they are drawn into a world that looks fully medical, fully endorsed, and fully plausible, because AI makes it child’s play to fabricate:

  • Clinicians
  • Pharmacists
  • Patient success stories
  • Scientific diagrams
  • GMP seals
  • Certificates “issued” by European regulators
  • Entire medical blogs posing as health journalism
  • Checkout pages that mimic e-commerce standards

Criminals are no longer faking a product. They are faking an entire ecosystem of legitimacy.

The New Phase: Copying Europe’s Healthcare Institutions

One of the most disturbing findings is the deliberate misuse of national public health identities. The trust that Europeans place in their healthcare systems, and which is often higher than in the U.S., is now being used against them.

Across all countries we examined, criminals have reproduced:

  • Logos
  • Regulatory seals
  • Color palettes
  • Institutional typography
  • Uniforms
  • Medical settings
  • National flags
  • Clinical imagery

Here are some of the examples we found.

United Kingdom: The NHS Has Become a Prime Target

The UK is now the most aggressively targeted country in Europe. Unlike in the U.S., scammers routinely place the NHS logo directly on their ads, alongside AI-generated “NHS doctors” and fabricated stories from “NHS colleagues.”

 

One campaign tells a lengthy narrative from “Daisy, 41, a nurse from Leeds,” and her partner “Tom, 46,” described as ambulance workers who lost “over 11 stone together.” The story is crafted to be emotionally relatable for a UK audience: long shifts, vending machine meals, exhaustion, feeling unable to care for oneself. It presents their discovery of a “GLP-1 oral solution” as a turning point in their NHS routine, implying that NHS staff themselves are using the product.

Live Well UK advert with NHS-style emblem

Highlighted text about “two NHS colleagues”

This story never happened. Daisy and Tom do not exist. The images of them in NHS scrubs are synthetic. The emotional arc, burnout, despair, redemption, is algorithmically optimized for engagement.

Other ads use more surreal AI-generated visuals: two overweight individuals in identical blue scrubs spraying a substance into their mouths in synchronized motion. The lighting, posture and movement patterns reveal the tell-tale artifacts of generative video.

These campaigns are designed to feel native to the UK’s social and healthcare culture. They exploit the deep trust the public places in the NHS. The NHS has become an attack surface.

Spain: Fake GLP-1 Ads Misusing AEMPS & Ministerio de Sanidad Logos

Spain is facing a surge of fraudulent “GLP-1 oral solutions” advertised as science-backed, 100% natural, and certified by local health authorities. These products include Diapason®, HHVB®, and LOTMAY®, none of which have anything to do with Spain’s official medical regulators.

One Spanish-language campaign boldly displays the AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) logo, the official Spanish medicines agency, suggesting that the product is endorsed and approved.

Spanish Diapason® GLP-1 7-en-1 ad using AEMPS-style certification seal

Another widely circulating ad uses the Ministerio de Sanidad branding to imply a government-backed breakthrough in weight loss science.


Official Ministerio de Sanidad / AEMPS real logo (for comparison)

A separate Spanish campaign for HHVB® GLP-1 uses vibrant red “¡Oferta caliente!” banners, “doctor recommended” badges, and a fake 123,000+ rating to create urgency and legitimacy.

N – HHVB® Spanish ad with “Oferta caliente” and fake star ratings

Across dozens of Spanish-language variants we reviewed, the pattern repeats:

  • “Results in 7 days”
  • “Certificación aemps”
  • “Producto respaldado por la ciencia europea”
  • Countdown timers
  • Aggressive green/white medical branding

None of these claims are real.

France: Fake “GLP-1” Solutions Using ANSM Branding & AI-Generated Pharmacists

France is experiencing an almost identical wave, but with local cultural adaptations and imitation of ANSM (Agence nationale de sécurité du médicament et des produits de santé) branding.

One popular French-language campaign advertises HHVB® GLP-1 SIX EN UN, plastered with French flags and “Fabriqué en France” banners to convey authenticity.

French HHVB® ad with “Fabriqué en France” and ANSM-style certification stamps

The ads often claim the product is recommended by French doctors and pharmacists. In one striking example, an AI-generated “pharmacienne” stands outside a French pharmacy (Parapharmacie) holding a GLP-1 box.

AI-generated French pharmacist holding GLP-1 product in front of a pharmacy

These are entirely synthetic personas created to mimic the authority of French healthcare professionals.

For comparison and clarity, here is the real ANSM logo that scammers are impersonating:

Official ANSM logo

Behavioral patterns in French campaigns match those in Spain:
rapid weight-loss promises, clinical-sounding language, product “ratings,” and badges referencing non-existent “certification Européenne GMP.”

These campaigns create a dangerous illusion: that these are French-produced, regulator-approved medical treatments, when they are nothing of the sort.

This fake French “Boutique Officielle” for Cvreoz® advertises a “GLP-1 6-en-1” liquid solution with “results in 7 days.” The packaging features the French flag and a mix of fabricated or misused certifications (NF Service, AB Bio, EU Ecolabel, CE), none of which apply to GLP-1 products. The site mimics the look of a legitimate French pharmacy, using green medical visuals and urgency tactics (“100 premiers clients”) to convince consumers it is an approved, France-made medical solution.

Cvreoz® / Gatlíve

This ad impersonates Pharmacie Lafayette and falsely claims the product is “ANSM certifié”, directly misusing France’s national drug safety authority name. The Croaie® GLP-1 + GIP packaging displays fake pharmaceutical seals (ISO, GMP, USP, FCC) and “Made in France” badges to appear clinically validated. The design imitates a real French pharmacy site, clean white layout, price drops, and refund guarantees, but the product and certifications are entirely fabricated.

Croaie® / Fake Pharmacie Lafayette

Germany: “Made in Germany” Trust Badges as a Weapon

This German-language advert for HHVB® GLP-1 Sechs in Eins uses Germany’s strong association with pharmaceutical precision to appear legitimate. The packaging displays the German flag alongside authoritative-looking seals — including GMP, HACCP, and “Herstellung in Deutschland” — none of which apply to GLP-1 medicines. The product claims to offer rapid weight loss, better sleep, higher energy and blood-sugar control, all through a single oral “6-in-1” solution. The ad layout mimics popular German e-commerce supplement sites, using bright trust badges, “Bestseller” labels and countdown discounts to create urgency.

HHVB GLP-1 Sechs in Eins (Germany)

This second German example uses the phrase “Aus Deutschland geliefert” and a German quality badge to present the product as locally made and medically verified. The packaging advertises a “GLP-1 7-in-1” formula with sweeping health claims: appetite suppression, sugar regulation, cardiovascular benefits, intestinal health and anti-aging effects. None of these claims are scientifically valid for an over-the-counter product. The design combines green medical imagery with seals resembling BfArM-style quality stamps, creating the illusion of official approval despite no such certification existing.

GLP-1 7-in-1 German variant

Italy: AIFA Impersonation and Herbal “Clinical” Solutions

In Italy, criminals adopt a hybrid approach — part clinical, part natural wellness. Campaigns mimic the visual style of AIFA, Italy’s medicines regulator, while simultaneously promoting herbal, “gentle” or “non-invasive” formulas.

Honxi Italian GLP-1 ad

The messaging appeals to a cultural affinity for phytotherapy and natural medicine but wraps it in the clothing of official pharmaceutical oversight.

Why Criminals Localize Their Scams So Precisely

What makes this phenomenon especially alarming is its sophistication. Criminals are not simply translating ads; they are rebuilding them from scratch to match the cultural, linguistic and regulatory context of each country. They understand:

  • The NHS is a uniquely powerful trust anchor in the UK
  • Germany associates safety with manufacturing standards
  • Italy responds to a blend of natural medicine and clinical language
  • Spain’s AEMPS branding is widely recognized
  • France’s reliance on pharmacists makes them ideal authority figures

Generative AI makes this level of localization effortless. A single campaign can be reinvented in minutes for another country — new names, new uniforms, new badges, new synthetic testimonials.

We are witnessing the next phase of AI-enabled cyber crime. Criminal groups can now generate entire fraudulent ecosystems, websites, doctors, reviews, branding, and regulatory approvals, at a scale that was impossible just a year ago. Organizations and public institutions need prevention-first security that can identify synthetic content, detect brand impersonation, and block malicious domains before they reach citizens.

Conclusion: A New Kind of Online Scam Europe Must Watch Out For

The rise of fake GLP-1 products shows how online scams are changing in 2025. Criminals are no longer just stealing passwords or bank details, they are now copying entire health products, complete with packaging, doctor “reviews,” fake pharmacies and even fake national health logos. AI has made it incredibly easy for scammers to make these sites look real, fast.

That means people who are trying to lose weight or improve their health are now becoming targets of highly convincing ads on social media. The NHS logo, the Spanish Ministry of Health seal, or France’s ANSM stamp can be added to a counterfeit website in seconds. For many consumers, it becomes almost impossible to tell real from fake.

How to Stay Safe

The best protection is awareness. A few simple habits can make a big difference:

  • Buy only from official pharmacies — check that the website is licensed in your country.
  • Be skeptical of social media ads — especially those promising fast results with no effort.
  • Double-check medical endorsements — scammers often invent doctors, clinics or NHS staff.
  • Look out for red flags — big discounts, countdown timers and “only a few left” warnings are common tricks used to push quick purchases.
A Shared Responsibility

This problem doesn’t belong to consumers alone. Health agencies, online platforms, payment providers and cyber security experts all need to work together to identify and remove these fake products before they reach the public.

AI has made it easier than ever for scammers to create convincing imitations, but with the right awareness and collaboration, it is still possible to stay ahead of them.

You may also like